Utrecht, Netherlands

Helmuth Gehart

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Koninklijke Nederlandse Akademie Van Wetenschappen. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Helmuth Gehart. Retrieved from https://idiyas.com/inventor/helmuth-gehart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2023-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Helmuth Gehart: Innovator in Differentiation Methods

Introduction

Helmuth Gehart is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of cell differentiation, particularly in the context of progenitor cells. His work has implications for therapeutic applications, showcasing the potential of stem cell research.

Latest Patents

Helmuth Gehart holds a patent for a differentiation method. This invention relates to differentiation methods for progenitor cells, such as mammalian epithelial stem cells. It includes differentiation media for use in these methods, as well as organoids and cells that can be obtained through these techniques. The patent also covers various therapeutic uses of these innovations.

Career Highlights

Gehart is affiliated with the Koninklijke Nederlandse Akademie van Wetenschappen, where he continues to advance research in his field. His work has garnered attention for its potential to revolutionize therapeutic approaches in regenerative medicine.

Collaborations

Helmuth Gehart collaborates with Johannes Carolus Clevers, a fellow researcher in the field. Their partnership enhances the scope and impact of their research endeavors.

Conclusion

Helmuth Gehart's contributions to differentiation methods represent a significant advancement in stem cell research. His innovative work continues to pave the way for future therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…